nocodazole has been researched along with apilimod in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, AB; Bennett, RS; Chen, YC; DeWald, LE; Dewey, WH; Dyall, J; Guha, R; Hensley, LE; Hoenen, T; Hughes, E; Jahrling, PB; Klumpp-Thomas, C; Liang, JY; Martin, S; McKnight, C; Michelotti, J; Morris, PJ; Nelson, EA; Olinger, GG; Thomas, C; Wang, A; White, JM; Xu, X; Zhou, H | 1 |
1 other study(ies) available for nocodazole and apilimod
Article | Year |
---|---|
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
Topics: Animals; Antiviral Agents; Biological Transport; Cell Line; Chlorocebus aethiops; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Hydrazones; Lysosomes; Macrophages; Marburgvirus; Morpholines; Nocodazole; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Toremifene; Triazines; Vero Cells; Virus Internalization | 2017 |